VPS39 divergent transcript (VPS39-DT)

The "VPS39 divergent transcript" (VPS39-DT) refers to a transcript in the genome that is named for its proximity or orientation relative to the gene VPS39, but there is no evidence it encodes a protein or represents a therapeutic target. VPS39-DT appears in gene databases as a descriptive entry without functional annotation, protein product, or classification as an enzyme, receptor, transporter, or other typical drug target class. No aliases, molecular functions, disease associations, or interacting drugs are reported. Its designation as a "divergent transcript" suggests it may be a non-coding RNA or an uncharacterized transcript, not a canonical target for therapeutic intervention[1][7]. Context and limitations: - No sources report VPS39-DT as a receptor, enzyme, transporter, or any molecular target class. - No information confirms biological function, disease linkage, or drug interaction. - The entry is only a transcript/genomic feature; "VPS39" (not "VPS39-DT") encodes a protein involved in vesicle-mediated trafficking and is relevant to cellular processes and some diseases, but "VPS39-DT" is distinct from the characterized protein-coding gene[2][3]. - Its presence in gene databases does not imply therapeutic target status[1][7].